Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Methoxy 4 Methylbenzylamine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102311352B details a safe, cost-effective 3-step synthesis from m-cresol, offering significant supply chain advantages for high-purity pharmaceutical intermediates.
Advanced synthesis of 2-methoxy-4-methylbenzylamine via safe reductive amination. Offers significant cost reduction in fine chemical manufacturing and high purity.